Straumann, CH1175448666

Citi reiterates Sell rating for Straumann stock

Published on 10/20/2026 at 12:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Straumann booked CHF 1.38 billion revenue. Straumann stock costs EUR 99.83 on October 20, 2026, 0.84 percent above the Xetra close.

Analyst stance and earnings date

  • Citi reiterated a Sell rating for Straumann on October 9, 2026.
  • Quarterly revenue reached CHF 1.38 billion versus CHF 1.35 billion a year earlier.
  • Straumann stock trades at EUR 99.83 at 12:49 p.m. CEST at Lang & Schwarz on October 20, 2026, 0.84 percent above the Xetra close of October 19, 2026.
  • The company will publish third-quarter sales on October 28, 2026.
Straumann Holding AG (CH0012280076) betreibt moderne Reinraum-Fertigung für präzise Dentalimplantate in der Schweiz, Illustration mit AI erstellt.

Straumann stock (ISIN CH1175448666) was trading at EUR 99.83 at Lang & Schwarz on October 20, 2026, at 12:49 p.m. CEST, 0.84 percent above the Xetra close of October 19, 2026 at EUR 99.00. The latest analyst signal was cautious: Markets Insider reported on October 9, 2026 that Citi reiterated a Sell rating for Straumann.

What does the next report need to show?

The central test is whether recent sales growth can keep pace with profit expansion. For the quarter ending June 30, 2026, Straumann generated CHF 1.38 billion in revenue, compared with CHF 1.35 billion a year earlier, an increase of 2.22 percent. Net profit rose to CHF 250.70 million from CHF 236.44 million, an increase of 6.03 percent, according to Markets Insider in its October 2, 2026 report.

When will Straumann report again?

Straumann will publish its third-quarter 2026 sales on October 28, 2026 at about 7:00 a.m. CEST and hold an English-language webcast from 10:30 to 11:30 a.m. CEST. The date and schedule were announced in the company communication carried by finanzen.ch on October 5, 2026.

Where the stock stands

The euro quote sits inside its current 52-week range, while the analyst split remains broad. Barclays maintained a Buy rating and a CHF 120.00 target on October 2, 2026, according to Markets Insider. The current market capitalization is CHF 14.7 billion, and the 52-week range is CHF 73.02 to CHF 109.80, both as of October 20, 2026.

Straumann was trading at EUR 99.83 at Lang & Schwarz on October 20, 2026, at 12:49 p.m. CEST, 0.84 percent above the Xetra close of October 19, 2026 at EUR 99.00. The further course of trading is shown by the continuously updated real-time quote of Straumann stock.

Straumann stock facts

  • Company: Straumann Holding AG
  • ISIN: CH1175448666
  • Ticker: STMN
  • Primary exchange: SIX Swiss Exchange
  • Price Lang & Schwarz (as of October 20, 2026, 12:49 p.m. CEST): EUR 99.83
  • Change versus Xetra close: plus 0.84 percent
  • Xetra close (October 19, 2026): EUR 99.00
  • Market capitalization: CHF 14.7 billion (as of October 20, 2026)
  • 52-week range: CHF 73.02-109.80 (as of October 20, 2026)
  • Sector / Industry: Healthcare / Medical Instruments and Supplies
  • Next earnings date: October 28, 2026

Market context: Market report SMI.

More news and analyses on Straumann stock

Disclaimer...
en | CH1175448666 | STRAUMANN | boerse | 70372315 | bgmi